PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,961 | -90.7% | 8,350 | -89.1% | 0.00% | -100.0% |
Q1 2023 | $236,957 | -1.1% | 76,685 | +35.4% | 0.00% | 0.0% |
Q4 2022 | $239,536 | +280.2% | 56,628 | +113.3% | 0.00% | – |
Q3 2022 | $63,000 | -25.0% | 26,545 | -9.4% | 0.00% | -100.0% |
Q2 2022 | $84,000 | -80.0% | 29,310 | -36.0% | 0.00% | -80.0% |
Q2 2021 | $420,000 | +69.4% | 45,777 | +92.7% | 0.01% | +25.0% |
Q2 2020 | $248,000 | – | 23,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |